Literature DB >> 22025242

The effect of ascorbic acid on the distribution of soluble Cr and Co ions in the blood and organs of rats.

Grace A Afolaranmi1, M Helen Grant.   

Abstract

Metal ions (Cr and Co) are released from metal orthopaedic implants in situ. We investigated tissue dissemination of Cr III, Cr VI and Co II ions in the body, and determined if administration of ascorbic acid (AA) affected their in vivo distribution using rats as a model system. Organs of rats treated with both Cr (VI) and Co (II) have higher metal ion levels when compared with control levels in the organs of rats without metal treatment. The reduced form of chromium, Cr III, is reported to be relatively impermeant to cell membranes in vitro, and in line with this, Cr III did not distribute into the organs of the rats after administration in vivo. Potent in vitro reduction of Cr (VI) to Cr III by AA was observed in this study. Prior intraperitoneal injection of AA lowered tissue uptake of both Cr VI and Co II, and increased faecal excretion, but not to a significant extent. AA may only be effective in increasing elimination of Cr VI at high concentrations when plasma reduction is saturated, and may be of limited therapeutic use in patients with orthopaedic implants.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22025242     DOI: 10.1002/jat.1744

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  2 in total

Review 1.  Adverse hematological effects of hexavalent chromium: an overview.

Authors:  Rina Rani Ray
Journal:  Interdiscip Toxicol       Date:  2017-05-17

2.  Cobalt Administration Causes Reduced Contractility with Parallel Increases in TRPC6 and TRPM7 Transporter Protein Expression in Adult Rat Hearts.

Authors:  Sarunya Laovitthayanggoon; Catherine J Henderson; Claire McCluskey; Margaret MacDonald; Rothwelle J Tate; M Helen Grant; Susan Currie
Journal:  Cardiovasc Toxicol       Date:  2019-06       Impact factor: 3.231

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.